Table 3. The association between lung function PES and spirometry measures in the Hunter Community Study cohort.
Phenotype | PES | Z value | p | PES R2 | NSNP |
---|---|---|---|---|---|
FEV1 | Dilated cardiomyopathy | 0.15 | 0.889 | 1.3 × 10−5 | 2404 |
Extension of telomeres | −0.18 | 0.861 | 1.7 × 10−5 | 44 | |
Pathways in cancer | 2.98 | 0.003 | 0.005 | 6214 | |
FVC | Circadian clock | 2.14 | 0.033 | 0.003 | 230 |
Class B/2 secretin family receptors | 3.14 | 0.002 | 0.005 | 76 | |
Extracellular matrix proteins | 3.50 | 5 × 10−4 | 0.007 | 16,390 | |
Pathways in cancer | 2.64 | 0.008 | 0.004 | 6212 | |
PES: pharmagenic enrichment score; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s. |
The Z value is the PES model coefficient divided by its standard error. The variance explained (R2) was the null model R2 subtracted from the full model with the PES as a predictor. The number of independent SNPs used to calculate the PES in this cohort is reported in the NSNP column. The reported results are from models unadjusted for genome-wide PGS.